… of off-label underdosed rivaroxaban and dabigatran were not … apixaban was associated
with a nearly 5-fold higher risk of … of low dose edoxaban in patients with non-valvular AF. The …

… The Edoxaban Low-Dose for EldeR CARE AF patients (… that in very elderly Japanese patients
with non-valvular AF who were … other DOACs (dabigatran, rivaroxaban, and apixaban) with …

… -control strategy for non-valvular atrial fibrillation (NVAF), … study, we found that neither
rivaroxaban nor dabigatran were … and edoxaban until December 2018, so data about apixaban …

… Non-valvular atrial fibrillation (NVAF) is a common cardiac … Four DOACs (dabigatran,
rivaroxaban, apixaban, and … In some patients taking very low-dose dabigatran (75 mg twice daily), …

… and safety of warfarin and dabigatran in patients with non-valvular atrial … Bleeding risk of
apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in Japanese patients …

… , this study concluded that apixaban was superior to warfarin … , dabigatran and rivaroxaban),
the risk of major bleeding was … claims) when rivaroxaban was compared with apixaban (…

… claim for apixaban, dabigatran, rivaroxaban, or warfarin from … approve their use in the
management of NVAF. Furthermore, … patient stroke risk, physician overestimation of bleeding risk, …

… overtime for dabigatran and rivaroxaban; whereas prescription of low dose apixaban and
edoxaban … Compared with warfarin, low dose apixaban was associated with a 37% lower …

… In this study, we investigate the survival benefits of low-dose … of thromboembolism and
hemorrhage in patients with non-valvular AF (… dabigatran and apixaban, for the warfarin group and …

… (ie, rivaroxaban, dabigatran and apixaban) versus VKAs from … the risk of mortality, bleeding
and stroke for apixaban versus … in the analysis, representing first-line treatment with warfarin, …